RGNX (REGENXBIO Inc.) Quarterly EPS earnings growth

Brandmark of REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX) relies on strategic pricing power in genetics driven by its unique NAV vectors for DNA delivery. Quarterly earnings per share growth illustrates the development trend, where the 47.80 metric confirms the current level. Its status as a recognized innovator in treating rare pathologies is complemented by a phase of planned liquidity expenditure to fund large-scale clinical trials.

REGENXBIO Inc (RGNX) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 11/17/2026

Summary analytical data breakdowns for regenxbio.com (RGNX)

- share price and expert price forecast:
Summary company analysis:REGENXBIO Corp - RGNX
Flagship merchandise of REGENXBIO Inc.

REGENXBIO Inc. (RGNX) management is skillfully monetizing gene therapy vector patents through licensing agreements. The earnings per share trend measures the effectiveness of this strategy by comparing actual income against market expectations. Negative values signal a risk of declining cash flows. It is critical for investors to distinguish temporary dips from a systemic crisis. The quarterly EPS trajectory provides an objective assessment of the business's resilience to drug development costs.

Main competitors

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months SLDB|Quarterly EPS earnings growth Ocugen Inc|Year-over-year earnings per share growth for the last twelve months PacBio Corp (PACB)|Year-over-year net earnings per share change for the last twelve months Benitec Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)